TGFB1 and neoplasm: The co-activation of TGF-β pathway in immunologically active tumors represents a mechanism of immune evasion, potentially leading to exclusion of CD8 T cells from the tumor tissue, ultimately diminishing the prognostic benefits of tumor immunogenicity [43].